Literature DB >> 18330934

H pylori recurrence after successful eradication.

Yaron Niv.   

Abstract

Recurrence of H pylori after eradication is rare in developed countries and more frequent in developing countries. Recrudescence (recolonization of the same strain within 12 mo after eradication) rather than reinfection (colonization with a new strain, more than 12 mo after eradication) is considered to be responsible for most of the cases. This observation was confirmed only in developed countries, while in developing countries a recent meta-analysis demonstrated a high rate of reinfection. The proportion of H pylori annual recurrence was 2.67% and 13.00% in developed and developing countries, respectively. Nested meta-analysis (only cases with a longer follow-up and a negative (13)CUBT a year after eradication) revealed annual recurrence rate of 1.45% [relative risk (RR), 0.54] and 12.00% (RR, 0.92) in developed and developing countries, respectively. These findings support the notion that in developed countries many cases of recurrence are due to recrudescence within the first year after eradication, with a 46% drop in the recurrence rate after the first year post eradication, while in developing countries reinfection is more pronounced, and continue at the same rate since eradication. A different approach for follow-up after H pylori eradication is probably needed in patients of developing countries, since reinfection is highly prevalent.

Entities:  

Mesh:

Year:  2008        PMID: 18330934      PMCID: PMC2693738          DOI: 10.3748/wjg.14.1477

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Reinfection rate following effective therapy against Helicobacter pylori infection in Japan.

Authors:  Masayasu Adachi; Motowo Mizuno; Kenji Yokota; Masatsugu Miyoshi; Yasuhiro Nagahara; Toshirou Maga; Kunihara Ishiki; Tomoki Inaba; Hioyuki Okada; Keiji Oguma; Takao Tsuji
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

2.  Incidence and factors influencing on Helicobacter pylori infection recurrence.

Authors:  B J Gómez Rodríguez; M Rojas Feria; M J García Montes; R Romero Castro; P Hergueta Delgado; F J Pellicer Bautista; J M Herrerías Gutiérrez
Journal:  Rev Esp Enferm Dig       Date:  2004-09       Impact factor: 2.086

3.  Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.

Authors:  Jae Hee Cheon; Nayoung Kim; Dong Ho Lee; Jung Mogg Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 2.566

4.  Oral cavity as a potential source of gastric reinfection by Helicobacter pylori.

Authors:  Elzbieta Karczewska; Joanna E Konturek; Peter C Konturek; Marta Cześnikiewicz; Edward Sito; Władysław Bielański; Nina Kwiecień; Wojciech Obtułowicz; Witold Ziemniak; Jolanta Majka; Eckhart G Hahn; Stanislaw J Konturek
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 5.  The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.

Authors:  Javier P Gisbert
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

6.  Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.

Authors:  P Hildebrand; P Bardhan; L Rossi; S Parvin; A Rahman; M S Arefin; M Hasan; M M Ahmad; K Glatz-Krieger; L Terracciano; P Bauerfeind; C Beglinger; N Gyr; A K Khan
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

7.  Role of partner's infection in reinfection after Helicobacter pylori eradication.

Authors:  Javier P Gisbert; Isabel García Arata; Daniel Boixeda; Mercedes Barba; Rafael Cantón; Antonio García Plaza; José María Pajares
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 2.566

8.  High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection.

Authors:  Yelda Leal-Herrera; Javier Torres; Thomas P Monath; Irma Ramos; Alejandro Gomez; Armando Madrazo-de la Garza; Margarita Dehesa-Violante; Onofre Muñoz
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

9.  Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan.

Authors:  Tadayoshi Okimoto; Kazunari Murakami; Ryugo Sato; Hajime Miyajima; Masaru Nasu; Jiro Kagawa; Masaaki Kodama; Toshio Fujioka
Journal:  Helicobacter       Date:  2003-06       Impact factor: 5.753

10.  Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.

Authors:  J P Gisbert; M Luna; B Gómez; J M Herrerías; J Monés; M Castro-Fernández; P Sánchez-Pobre; A Cosme; D Olivares; J M Pajares
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

View more
  21 in total

1.  Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.

Authors:  Theodora Choli-Papadopoulou; Filippos Kottakis; Georgios Papadopoulos; Stefanos Pendas
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

2.  Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.

Authors:  J A da Silva Medeiros; T M F O Gonçalves; L Boyanova; M I de Correia Pereira; J N da Silva Paiva de Carvalho; A M de Sousa Pereira; A M Silvério Cabrita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-05       Impact factor: 3.267

3.  Helicobacter pylori and oral pathology: relationship with the gastric infection.

Authors:  Isabel Adler; Andrea Muiño; Silvia Aguas; Laura Harada; Mariana Diaz; Adriana Lence; Mario Labbrozzi; Juan Manuel Muiño; Boris Elsner; Alejandra Avagnina; Valeria Denninghoff
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.

Authors:  Qian Ren; Xiang Yan; YongNing Zhou; Wei Xin Li
Journal:  Cochrane Database Syst Rev       Date:  2016-02-07

Review 5.  Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme.

Authors:  F Dhalla; S P da Silva; M Lucas; S Travis; H Chapel
Journal:  Clin Exp Immunol       Date:  2011-04-06       Impact factor: 4.330

Review 6.  Helicobacter pylori persistence in children: distinguishing inadequate treatment, resistant organisms, and reinfection.

Authors:  Diana A Moya; Karen D Crissinger
Journal:  Curr Gastroenterol Rep       Date:  2012-06

7.  Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial.

Authors:  Anthony J Lembo; Robert A Ganz; Sunil Sheth; David Cave; Ciaran Kelly; Philip Levin; Peter T Kazlas; Paul C Baldwin; William R Lindmark; Jonathan R McGrath; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2009-07       Impact factor: 4.025

Review 8.  Quality of healing of gastric ulcers: Natural products beyond acid suppression.

Authors:  Napapan Kangwan; Jong-Min Park; Eun-Hee Kim; Ki Baik Hahm
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

Review 9.  Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection.

Authors:  Pradeep S Anand; Kavitha P Kamath; Sukumaran Anil
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

10.  Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701).

Authors:  Carolina Porras; Jesse Nodora; Rachael Sexton; Catterina Ferreccio; Silvia Jimenez; Ricardo L Dominguez; Paz Cook; Garnet Anderson; Douglas R Morgan; Laurence H Baker; E Robert Greenberg; Rolando Herrero
Journal:  Cancer Causes Control       Date:  2012-12-12       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.